Our Purpose
Asia’s First
Client-Facing Commercialization Partner for Biotech Start-ups
We bring biotech innovation to market.
ONE-STOP HOLISTIC SOLUTION • COMMERCIALIZATION • HEALTH & WELLNESS • PRECISION MEDICINE • PRECLINICAL RESEARCH • ONE-STOP HOLISTIC SOLUTION • COMMERCIALIZATION • HEALTH & WELLNESS • PRECISION MEDICINE • PRECLINICAL RESEARCH
Bridging the Gap between Breakthrough Science and Market Success
Client-Facing Representation
We act as your external business development team, engaging directly with potential customers and partners.
Execution-Focused Commercialization
We go beyond strategy, delivering real-world outcomes through targeted outreach, lead generation, and relationship-building.
Biotech Specialization
Our expertise spans organoids, sequencing, diagnostics, and other deep tech platforms. We understand the science and the market.
Performance-Based Model
We align our success with yours, offering low-risk, results-driven engagement structures.
Asia-Centric Expansion
With strong roots in Singapore and Hong Kong, we help start-ups navigate regulatory, cultural, and commercial landscapes across the region.
Advancing Lifesciences Through
Next-Generation Technologies
[01]
Health & Wellness
A holistic precision ecosystem that uncovers insights across your genetics, neurological health, immune responses, and full biological profile.
[02]
Precision Medicine
Step into the future of cancer care with a transformative approach that blends precision diagnostics, personalized therapeutics, and integrative wellness.
[03]
Advancing discovery through humanized preclinical models that mimic human biology. Bridging the gap between research and precision medicine.
Our Founders
Emily CHEUNG 張慧儀
Co-founder and Chief EXECUTIVE Officer
She brings a multidisciplinary background spanning commercialization, operations, and healthcare service innovation. Her experience integrates strategic planning with hands‑on execution, enabling her to transform complex ideas into practical, scalable solutions that advance both organizational performance and patient‑centered innovation.
Benson TO 杜本辰
Co-founder and Chief Technology Officer
He brings a multidisciplinary approach that bridges science and strategy, a rare blend of technical acumen and commercial insight. Operating at the intersection of innovation and execution, he translates complex scientific concepts into scalable, market‑ready solutions that drive organizational growth and industry impact.
Strategic Partners
Advancing Lifesciences Through Next-Generation Technologies